ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 210717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 210717; 2) Community: the network communities that were significantly associated with the response to NSC 210717; 3) Molecule: the relationships between components within communities and NSC 210717; 4) MDR: the compounds that were significantly associated with the NSC 210717.

NSC Compound Enrichment Correlation
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.009562217715459 0.32351731
NSC 691533 Null 0.009562217715459 0.23482063
NSC 693545 4-Acridinecarboxamide, 9-amino-N-[2-[(2-aminoethyl)amino]ethyl]-5-methyl-, trihydrochloride 0.009562217715459 0.37327047
NSC 699925 Null 0.009562217715459 0.24924525
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0126882509540132 0.14227284
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0126882509540132 0.40834946
NSC 603071 Aminocamptothecin 0.0126882509540132 0.42516282
NSC 606497 Camptothecin Derivative 0.0126882509540132 0.4366442
NSC 606499 Camptothecin Derivative 0.0126882509540132 0.42575153
NSC 67091 Null 0.0126882509540132 0.28429951
Total:32  Current:6    [First] [Prev] [Next] [Last]